Disease assessment
HGG, Tumor
DISEASE PROGRESSION, SOLID TUMORS, TUMOR, GIST
For solid tumors (ATC, BTC, GIST, LGG, HGG and ASI), assessments were done at baseline (≤35 days before enrollment) and post-baseline every 8 weeks during the first 48 weeks and then every 12 weeks thereafter, until disease progression. Tumor assessments were conducted as per RECIST version 1.1 (ref. 